Skip to main content
Fig. 5 | EJNMMI Radiopharmacy and Chemistry

Fig. 5

From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model

Fig. 5

Cell uptake of [89Zr]Zr-DFO-NY003 and [177Lu]Lu-DTPA-NY003 in MDA-MB-231 (A) and ACHN (B) cells at different time points. (Block = co-incubation with non-radiolabeled NY003 and radiotracers for 48 and 72 h. Values were expressed as mean ± SD, n = 6. **Means P < 0.01, ns means not statistically significant)

Back to article page